Using Gephi and VOS as landscaping tools, the authors of the attached recent publication analyse and display the IP relationships between key players of the Covid-19 mRNA vaccine domain and between technical terms appearing in corresponding claims and abstracts, see Figures 1 and 2. The companies and institutes behind both the well known vaccines already on the market as well as of those still in development can be seen in Figure 1 of the paper. In view of the supplementary data it is apparent that prior to conducting the network analysis, the authors performed a search of relevant patents the result of which was fed into the network analysis tools.
IP landscaping applied to Covid-19 mRNA vaccines
April 5, 2022
More posts by Roger Abseher